WHO-led COVID drug scheme doubles down on antibodies
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids.
All News Here
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids.
German pharmaceutical company BioNTech test comes a week after clinical trials by Oxford University scientists in the United Kingdom.